Pharmaceutical Industry news, analysis and insights
Medtronic has received the CE mark for its extravascular defibrillator. The Aurora EV-ICD MRI SureScan and epsila EV MRI SureScan defibrillation lead treat abnormally fast heart rhythms, which can lead to sudden cardiac arrest.
REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for its drug rxg-314, which was developed by the company’s NAVXpress bioreactor platform process.
J&J has begun scaling back its COVID-19 vaccine producation due to the falling demand for the jabs
Eli Lilly has announced plans to invest $450m in manufacturing facilities at Research Triangle Park in North Carolina, US
Daiichi Sankyo shares plans to build its first mRNA COVID-19 vaccine factory in Japan